All Companies

LLY

Eli Lilly & Co.

Pharmaceutical Preparations

$1,148.84updated Aug 1, 2026

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Total Trades

50

Politicians Trading

21

Last Traded

Jul 10, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Dan NewhouseRJul 17, 2026Jul 10, 2026Sell$1,001 - $15,000-3.34%
Gilbert Ray Cisneros, Jr.DJul 2, 2026Jun 10, 2026Buy$50,001 - $100,000+1.10%
Byron DonaldsRMay 13, 2026Apr 2, 2026Buy$1,001 - $15,000+22.79%
Byron DonaldsRMay 13, 2026Apr 2, 2026Buy$1,001 - $15,000+22.79%
Alan ArmstrongRJul 21, 2026Mar 27, 2026Sell$1,001 - $15,000+30.81%
David TaylorRMar 6, 2026Feb 26, 2026Buy$1,001 - $15,000+12.41%
David TaylorRFeb 20, 2026Feb 9, 2026Sell$1,001 - $15,000+9.97%
David TaylorRFeb 2, 2026Jan 16, 2026Sell$1,001 - $15,000+10.64%
Markwayne MullinRJan 16, 2026Dec 29, 2025Buy$15,001 - $50,000+6.50%
Angus S. King Jr.IJan 26, 2026Dec 29, 2025Buy$1,001 - $15,000+6.50%
Julie JohnsonDJan 15, 2026Dec 18, 2025Sell$1,001 - $15,000+8.70%
David TaylorRDec 19, 2025Dec 10, 2025Sell$1,001 - $15,000+15.62%
John BoozmanRDec 8, 2025Nov 21, 2025Sell$1,001 - $15,000+8.41%
Gilbert Ray Cisneros, Jr.DDec 15, 2025Nov 18, 2025Buy$1,001 - $15,000+11.53%
Julie JohnsonDDec 11, 2025Nov 13, 2025Sell$1,001 - $15,000+12.32%
Shelley Moore CapitoRNov 4, 2025Oct 24, 2025Buy$1,001 - $15,000+39.18%
Val T. HoyleDOct 10, 2025Sep 23, 2025Sell$1,001 - $15,000+53.80%
John BoozmanRSep 12, 2025Aug 22, 2025Buy$1,001 - $15,000+61.43%
David TaylorRSep 2, 2025Aug 14, 2025Buy$1,001 - $15,000+67.85%
David TaylorRSep 2, 2025Aug 14, 2025Buy$15,001 - $50,000+67.85%
Julie JohnsonDSep 11, 2025Aug 14, 2025Sell$1,001 - $15,000+67.85%
John BoozmanRSep 12, 2025Aug 11, 2025Buy$1,001 - $15,000+80.86%
Lisa C. McClainRAug 13, 2025Jul 16, 2025Sell$1,001 - $15,000+45.46%
Lisa C. McClainRAug 13, 2025Jul 10, 2025Buy$1,001 - $15,000+45.30%
Lisa C. McClainRAug 13, 2025Jun 9, 2025Sell$1,001 - $15,000+48.48%
Jonathan L. JacksonDJul 14, 2025Jun 3, 2025Sell$15,001 - $50,000+53.02%
Gilbert Ray Cisneros, Jr.DJun 6, 2025May 30, 2025Sell$1,001 - $15,000+55.74%
Jonathan L. JacksonDAug 25, 2025May 21, 2025Sell$1,001 - $15,000+58.47%
Marjorie Taylor GreeneRMay 19, 2025May 14, 2025Buy$1,001 - $15,000+60.55%
Josh GottheimerDJun 11, 2025May 13, 2025Sell$1,001 - $15,000+53.99%
Jefferson ShreveRJun 22, 2025May 12, 2025Sell$100,001 - $250,000+52.05%
Val T. HoyleDSep 12, 2025May 6, 2025Sell$1,001 - $15,000+48.21%
Marjorie Taylor GreeneRMay 6, 2025May 5, 2025Buy$1,001 - $15,000+39.85%
Josh GottheimerDJun 11, 2025May 1, 2025Buy$1,001 - $15,000+44.67%
Jonathan L. JacksonDAug 25, 2025Apr 23, 2025Buy$1,001 - $15,000+38.51%
Jonathan L. JacksonDMay 13, 2025Apr 21, 2025Buy$15,001 - $50,000+40.44%
Bruce WestermanRMay 12, 2025Apr 21, 2025Sell$1,001 - $15,000+40.44%
Tommy TubervilleRMay 15, 2025Apr 15, 2025Sell$15,001 - $50,000+51.73%
Dan NewhouseRMay 16, 2025Apr 11, 2025Sell$1,001 - $15,000+56.86%
Josh GottheimerDMay 14, 2025Apr 9, 2025Sell$1,001 - $15,000+52.42%
Robert BresnahanRApr 28, 2025Apr 8, 2025Sell$1,001 - $15,000+58.19%
Julie JohnsonDMay 14, 2025Apr 7, 2025Sell$1,001 - $15,000+58.74%
Josh GottheimerDApr 10, 2025Mar 10, 2025Sell$1,001 - $15,000+38.45%
Ashley MoodyRMar 22, 2025Mar 6, 2025Buy$100,001 - $250,000+25.86%
Bruce WestermanRApr 16, 2025Mar 3, 2025Buy$1,001 - $15,000+23.57%
Josh GottheimerDMar 6, 2025Feb 19, 2025Sell$1,001 - $15,000+32.50%
Ron WydenDFeb 21, 2025Feb 10, 2025Sell$50,001 - $100,000+32.22%
Ron WydenDFeb 21, 2025Jan 22, 2025Buy$50,001 - $100,000+52.37%
Marjorie Taylor GreeneRJan 27, 2025Jan 21, 2025Buy$1,001 - $15,000+54.76%
Josh GottheimerDFeb 10, 2025Jan 8, 2025Sell$1,001 - $15,000+45.94%